Notices. Notice; correction
221 words·~1 min read·
/register/2017/12/14/2017-26938·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2015-D-4562] Public Workshop on Safety Assessment for Investigational New Drug Safety Reporting; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration is correcting a notice entitled “Safety Assessment for Investigational New Drug Safety Reporting; Public Workshop” that appeared in the **Federal Register** of November 27, 2017.
The document announced a public workshop to engage external stakeholders in discussions related to finalizing the draft guidance entitled “Safety Assessment for IND Safety Reporting.” The date of the meeting has changed. FOR FURTHER INFORMATION CONTACT: Lauren Wedlake, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 6362, Silver Spring, MD 20993, 301-796-2728, *Lauren.Wedlake@fda.hhs.gov.* In the **Federal Register** of Monday, November 27, 2017, in FR Doc. 2017-25454, the following correction is made: 1.
On page 56036, in the first column, in the first sentence of the DATES section, “The public workshop will be held on January 11, 2018, from 9 a.m. to 4 p.m., Eastern Time.” is corrected to read “The public workshop will be held on March 8, 2018, from 9 a.m. to 4 p.m., Eastern Time.” Dated: December 8, 2017. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2017-26938 Filed 12-13-17; 8:45 am]